tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Venture Life Confirms Total Voting Rights Following Year-End Share Capital Update

Story Highlights
  • Venture Life reports 126,513,831 ordinary shares currently carrying voting rights.
  • The updated voting rights figure guides shareholders’ disclosure obligations under FCA rules.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Venture Life Confirms Total Voting Rights Following Year-End Share Capital Update

Claim 70% Off TipRanks Premium

The latest announcement is out from Venture Life ( (GB:VLG) ).

Venture Life Group has confirmed that, as of 31 December 2025, it has 128,253,812 ordinary shares of 0.3 pence in issue, of which 1,739,981 are held in treasury, leaving 126,513,831 shares carrying voting rights. The company noted that this total voting rights figure will serve as the reference point for shareholders in determining whether they must disclose holdings or changes in their interests under the FCA’s Disclosure Guidance and Transparency Rules, providing clarity and transparency over the group’s current capital and governance structure.

The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.

Spark’s Take on GB:VLG Stock

According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.

Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.

To see Spark’s full report on GB:VLG stock, click here.

More about Venture Life

Venture Life Group is a UK-headquartered international consumer self-care company focused on commercialising over-the-counter health products for the global self-care market. Its portfolio spans women’s intimate healthcare (Balance Activ), ENT care (Earol), energy and glucose management and hypoglycaemia (Lift and Glucogel ranges), and products supporting the hormonal lifecycle (Health & Her), distributed through pharmacies, health and beauty retailers, grocery chains and e-commerce channels worldwide, either directly or via international distribution partners.

Average Trading Volume: 191,413

Technical Sentiment Signal: Buy

Current Market Cap: £83.5M

Learn more about VLG stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1